NCT06368726
Result of tDCS in ASD Children With Comorbidities Like PANDAS, Rare Genetic Diseases or Autoimmune Disorders
Enrolling by Invitation
PHASE1Ages 6–11InterventionalTreatmentSpanish Foundation for Neurometrics DevelopmentInvestigator-initiated
~180 participants
Updated 2026-05-19 on ClinicalTrials.gov
What's tested:tDCS or Transcranial Direct Current StimulationRisperidone
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
FFT
Measured over 12 months
+3 more outcomes measured
Conditions
Where it's being run
1 sites across 1 statesNew Mexico1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Age between 7 and 15 years old
Diagnosis: PDD, ASD or PANDAS
Have genetic alterations with geneticist reports like: mutation, random mating between organisms, random fertilization or crossing over (or recombination) between chromatids of homologous chromosomes during meiosis.
Natural birth without caesarean or complications
Normal Pregnancy
Exclusion
Head Trauma
Brain Injuries like meningitis or encephalitis, including SaRS, Herpes or MERS infections
Epilepsy
Rare Diseases with Auto-Immune Disease
Rare diseases with Endocrinology problems
Fever or Biochemical problems in the First Blood Test (First Visit)
Vaccines Reactions
What this trial measures
- FFT12 months
Change in Voltage for every frequency band
- Power Density Spectrum Changes or PSD12 Months
Amplitude of the PSD
- ERP MMN changes12 months
Changes in P300 wave amplitude
- ERP MMN Changes12 Monts
Changes in P300 wave latency